HLA-Cw6 is an allele associated with psoriasis susceptibility and increased severity. Normally, this form of psoriasis is present at a younger age because of its genetic origin. Depending on the age of onset, different clinical patterns have been identified for psoriasis: EOP, presenting <40 years of age and LOP, presenting ≥40 years of age. A difference in treatment response has been observed for EOP versus LOP in European and East Asian populations, but there is a lack of data from Indian patients. Dr Farhat Fatima (M. R. Bangur Hospital, India) shared the results of a descriptive, cross-sectional study that compared clinical patterns of HLA-C2w6 association of EOP versus LOP in Indian patients [1].
Medical history and clinical variables were collected, as well as blood samples that were taken from a subset of patients to test for the presence of HLA-Cw6 [1]. Of the total study population (n=250), 138 patients were allocated to the EOP group and 112 in the LOP group. Sex ratio differed significantly (P=0.01) between groups; more men were included in both groups. Family history of psoriasis was higher in EOP than LOP (12.3% vs 3.6%; P=0.01).
In both groups, the most common site involved were the lower limbs (70% EOP; 75% LOP; P=0.28). A significantly higher percentage of nail involvement was found for EOP compared with LOP (55.8% vs 34%; P-value not shown). HLA-Cw6 analysis was done in 15 EOP and 15 LOP patients. A significantly higher percentage of patients with EOP were positive for HLA-Cw6 than LOP patients (73.3% vs 20%; P-value not shown). For a better understanding of the role of HLA-Cw6 in psoriasis, a higher number of patients and healthy controls should be analysed.
The current study supports the concept of 2 subtypes of psoriasis based on the age of onset: EOP and LOP. Further recruitment of patients and adding more clinical parameters, such as comorbidities and treatment response, are required for future investigation on the difference between the 2 subtypes.
- Fatima F. Early vs late onset psoriasis: comparative study of clinical variables and association with HLACW6. Abstract 234, ICD 2021, 10–13 November 2021.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Comparing routes of administration of methotrexate in psoriasis patients Next Article
Autologous serum therapy benefits chronic spontaneous urticaria »
« Comparing routes of administration of methotrexate in psoriasis patients Next Article
Autologous serum therapy benefits chronic spontaneous urticaria »
Table of Contents: ICD 2021
Featured articles
Autologous serum therapy benefits chronic spontaneous urticaria
ICD Round-Up Articles
An unusual case of E. coli cellulitis in an immunocompetent patient
Autologous serum therapy benefits chronic spontaneous urticaria
Comparing routes of administration of methotrexate in psoriasis patients
Expanding the toolbox: what is new in melanoma detection?
Equity in dermatology: Skin Care For All
Challenges in diagnosis and treatment of leprosy in Brazil
A PASSION to provide dermatological care in LMICs
Paediatric dermatology in Tunisia: common diagnoses
Registry of vitiligo patients aims to break the stigma
10% thioglycolic acid gel peels: a safe and efficient option for pigmented purpuric dermatosis
Benefits of microneedling with platelet-rich plasma for acne scars
Related Articles
December 2, 2021
Ceramides and their role in skincare
December 2, 2021
A PASSION to provide dermatological care in LMICs
December 2, 2021
Registry of vitiligo patients aims to break the stigma
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com